Cargando…
A New Optimized Version of a Colorectal Cancer-Targeted Immunotoxin Based on a Non-Immunogenic Variant of the Ribotoxin α-Sarcin
SIMPLE SUMMARY: Antitumor therapy with immunotoxins is limited by problems of immunogenicity and low efficacy in solid tumors. The different strategies to solve these problems include obtaining non-immunogenic variants of the toxins used as well as optimizing their release into the cytosol to increa...
Autores principales: | Narbona, Javier, Gordo, Rubén G., Tomé-Amat, Jaime, Lacadena, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954630/ https://www.ncbi.nlm.nih.gov/pubmed/36831456 http://dx.doi.org/10.3390/cancers15041114 |
Ejemplares similares
-
Inclusion of a Furin Cleavage Site Enhances Antitumor Efficacy against Colorectal Cancer Cells of Ribotoxin α-Sarcin- or RNase T1-Based Immunotoxins
por: Ruiz-de-la-Herrán, Javier, et al.
Publicado: (2019) -
Efficient in vivo antitumor effect of an immunotoxin based on ribotoxin α-sarcin in nude mice bearing human colorectal cancer xenografts
por: Tomé-Amat, Jaime, et al.
Publicado: (2015) -
A deimmunised form of the ribotoxin, α-sarcin, lacking CD4(+) T cell epitopes and its use as an immunotoxin warhead
por: Jones, Tim D., et al.
Publicado: (2016) -
The ribotoxin α-sarcin can cleave the sarcin/ricin loop on late 60S pre-ribosomes
por: Olombrada, Miriam, et al.
Publicado: (2020) -
Nanobody-Based EGFR-Targeting Immunotoxins for Colorectal Cancer Treatment
por: Narbona, Javier, et al.
Publicado: (2023)